The Global Cellulite Treatment Market size is expected to reach $5.4 billion by 2031, rising at a market growth of 10.1% CAGR during the forecast period.
Using high-energy acoustic waves, a relatively new treatment option known as acoustic wave therapy targets and targets cellulite in order to break it down. This non-invasive treatment has been shown to improve the appearance of cellulite, reduce skin laxity, and improve overall skin texture. Consequently, the non-invasive would generate approximately 43.0 % share in the market by 2031. These treatments are more effective, safer, and more comfortable than traditional surgical procedures. As a result, more patients opt for these innovative treatments to achieve smoother, firmer, and more youthful-looking skin.
As more individuals become aware of cellulite's impact on their appearance and self-esteem, there has been a corresponding surge in the demand for effective treatments to address this common aesthetic concern. This heightened awareness has been fostered by major international bodies, organizations, and associations dedicated to promoting skin health and raising awareness about cellulite. Hence, the increasing awareness and concern about cellulite have driven the demand for cellulite treatments.
Additionally, As people age, their skin loses elasticity and firmness, making them more prone to cellulite. According to the World Health Organization, one in six people will be 60 or older by 2030. At this time, there will be approximately 1.4 billion people aged 60 or older, a significant increase over the 1 billion projected for 2020. Thus, this demographic trend has increased the demand for cellulite treatments.
However, Cellulite treatments can vary widely in cost depending on the type of treatment and the provider. More advanced or invasive procedures, such as laser therapy or radiofrequency treatments, are more expensive than non-invasive options. Thus, the high cost of effective cellulite treatments may deter their adoption, limiting the market's growth.
Furthermore, The pandemic led to a delay in treatment-seeking behavior among some consumers. Economic uncertainty and concerns about the virus caused some individuals to postpone cosmetic procedures, including cellulite treatments until the situation improves. This delay impacted providers' revenue and led to a backlog of patients seeking treatment. Thus, the pandemic had an overall negative impact on the market.
Using high-energy acoustic waves, a relatively new treatment option known as acoustic wave therapy targets and targets cellulite in order to break it down. This non-invasive treatment has been shown to improve the appearance of cellulite, reduce skin laxity, and improve overall skin texture. Consequently, the non-invasive would generate approximately 43.0 % share in the market by 2031. These treatments are more effective, safer, and more comfortable than traditional surgical procedures. As a result, more patients opt for these innovative treatments to achieve smoother, firmer, and more youthful-looking skin.
As more individuals become aware of cellulite's impact on their appearance and self-esteem, there has been a corresponding surge in the demand for effective treatments to address this common aesthetic concern. This heightened awareness has been fostered by major international bodies, organizations, and associations dedicated to promoting skin health and raising awareness about cellulite. Hence, the increasing awareness and concern about cellulite have driven the demand for cellulite treatments.
Additionally, As people age, their skin loses elasticity and firmness, making them more prone to cellulite. According to the World Health Organization, one in six people will be 60 or older by 2030. At this time, there will be approximately 1.4 billion people aged 60 or older, a significant increase over the 1 billion projected for 2020. Thus, this demographic trend has increased the demand for cellulite treatments.
However, Cellulite treatments can vary widely in cost depending on the type of treatment and the provider. More advanced or invasive procedures, such as laser therapy or radiofrequency treatments, are more expensive than non-invasive options. Thus, the high cost of effective cellulite treatments may deter their adoption, limiting the market's growth.
Furthermore, The pandemic led to a delay in treatment-seeking behavior among some consumers. Economic uncertainty and concerns about the virus caused some individuals to postpone cosmetic procedures, including cellulite treatments until the situation improves. This delay impacted providers' revenue and led to a backlog of patients seeking treatment. Thus, the pandemic had an overall negative impact on the market.
By Gender Analysis
Based on gender, the market is segmented into male and female. The male segment acquired a 27.05 % revenue share in the market in 2023. Men increasingly seek treatments to improve their appearance and address aesthetic concerns, including cellulite. Additionally, as the stigma surrounding cosmetic procedures diminishes, more men are exploring options to enhance their physical appearance, including reducing the appearance of cellulite. According to the gender breakouts for the 2022 American Society of Plastic Surgeons (ASPS) Procedural Statistics, men accounted for exceptional growth - a 207% rise in total cosmetic procedures since 2019.By Procedure Type Analysis
On the basis of procedure type, the market is classified into non-invasive, minimally invasive, and topical. The non-invasive segment acquired the 44.14 % revenue share in the market in 2023. Patients are able to return to their regular activities almost immediately after receiving non-invasive treatments because these treatments typically require only a short period of downtime. This convenience attracts those with busy lifestyles who cannot afford extended recovery periods. As technology advances, non-invasive treatments are likely to become even more popular among those looking to improve the appearance of their skin.
By Cellulite Type Analysis
Based on cellulite type, the market is characterized into soft cellulite, hard cellulite, and edematous. The edematous segment procured a 15.47 % growth rate in the market in 2023. Edematous cellulite is a type of cellulite characterized by fluid retention and swelling in the affected areas. Hormonal imbalances, poor circulation, and lifestyle factors like diet and exercise are factors that are frequently associated with this condition. The demand for edematous cellulite treatment is on the rise, driven by several factors, including increasing awareness of cellulite as a common concern, the desire for smoother skin, and advancements in treatment options.By End-User Analysis
By end user, the market is divided into hospitals, clinics & beauty centers, and others. The clinics & beauty centers segment witnessed the 52.27 % revenue share in the market in 2023. Aestheticians, dermatologists, and trained technicians are examples of the types of skilled professionals that are frequently employed by beauty centers and clinics that specialize in the treatment of cellulite. These professionals have extensive experience using these treatments. They may also offer complementary services, such as body contouring and skin tightening treatments, to enhance the results of cellulite reduction procedures.By Regional Analysis
Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The Asia Pacific segment witnessed a 18.45 % growth rate in the market in 2023. Countries such as China, India, and Japan are driving market growth. These countries have large populations with increasing disposable income levels, leading to a growing demand for aesthetic procedures, including cellulite treatments. Additionally, the influence of Western beauty standards and the rise of social media contribute to the growing acceptance of cellulite treatments in these regions.Recent Strategies Deployed in the Market
- Jan-2024: Solta Medical, a subsidiary of Bausch Health Companies Inc., has received approval from China's National Medical Product Administration (NMPA) for its Thermage FLX and the TR-4 Return pad. These are non-invasive treatments utilizing radiofrequency technology aimed at tightening and enhancing the smoothness and texture of the skin's surface, ultimately optimizing a patient's appearance. Thermage proves versatile and effective, suitable for all skin types and genders, and applicable to various areas on the face, body, and around the eyes.
- Mar-2023: Sinclair Pharma Ltd. has introduced a novel product called Lanluma, a collagen-stimulating injectable filler. Lanluma is designed to reshape, volumize, and enhance body contours. The minimally invasive treatment entails the injection of Poly-L-lactic acid (PLLA), which enhances skin tightness and texture, augments curves in flat or sagging buttocks, reduces cellulite and dimples, enhances buttock shape and volume, and addresses natural or post-surgical concerns like atrophy and lipoatrophy.
- Feb-2023: Candela Corporation introduces its latest innovation, the Profound Matrix system, designed for radiofrequency-based skin treatments. This system employs radiofrequency microneedles to address skin concerns across various stages of the aging process. With features like Sublime, Sublative RF, and the new Matrix Pro applications, it provides bipolar radiofrequency treatment to improve the appearance of fine lines and wrinkles.
- Aug-2022: Allergan Aesthetics, an AbbVie company, launches SkinMedica® Firm & Tone Lotion for Body, the inaugural product from its professional-grade skincare line. Formulated to combat visible signs of body skin aging, it addresses crepey skin, uneven texture, firmness, tone, and sagging. Featuring ingredients like Green Microalgae, Shitake Mushroom Extracts, Lemon Balm Extract, Coffea Arabica Seed Oil, Caffeine, Hydrolyzed Rice Protein, and Japanese Parsley, it supports various skin functions including dermal extracellular matrix components, cellular clearance and recycling, antioxidant protection, and balanced lipid metabolism.
- Feb-2022: Sinclair Pharma Ltd. has entered into an agreement with Viora Ltd., a medical device company specializing in medical aesthetic systems. The agreement involves Sinclair's acquisition of Viora, enhancing Sinclair Cocoon's product range and extending its commercial footprint in the United States through various technologies.
- Dec-2021: Allergan Aesthetics, a subsidiary of AbbVie Inc., has finalized the acquisition of Soliton, Inc., a medical device company specializing in acoustic shockwave technology for tattoo and cellulite removal. With this acquisition, the company seeks to enhance its solution portfolio by integrating a proven treatment for cellulite, complementing its existing range of non-invasive body contouring treatments.
List of Key Companies Profiled
- Candela Corporation (Syneron Medical)
- Bausch Health Companies, Inc.
- Sinclair Pharma Ltd. (Huadong Medicine Co., Ltd.)
- AbbVie, Inc.
- Cynosure, LLC (Clayton, Dubilier & Rice, LLC)
- Hologic, Inc.
- Galderma S.A.
- Zimmer MedizinSysteme GmbH
- Endo International PLC
- Merz Pharma GmbH & Co. KGaA
MarketReport Segmentation
By Gender
- Female
- Male
By Procedure Type
- Non-invasive
- Topical
- Minimally Invasive
By Cellulite Type
- Soft Cellulite
- Hard Cellulite
- Edematous
By End User
- Clinics & Beauty Centers
- Hospitals
- Others
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 5. Global Cellulite Treatment Market by Gender
Chapter 6. Global Cellulite Treatment Market by Procedure Type
Chapter 7. Global Cellulite Treatment Market by Cellulite Type
Chapter 8. Global Cellulite Treatment Market by End User
Chapter 9. Global Cellulite Treatment Market by Region
Chapter 10. Company Profiles
Companies Mentioned
- Candela Corporation (Syneron Medical)
- Bausch Health Companies, Inc.
- Sinclair Pharma Ltd. (Huadong Medicine Co., Ltd.)
- AbbVie, Inc.
- Cynosure, LLC (Clayton, Dubilier & Rice, LLC)
- Hologic, Inc.
- Galderma S.A.
- Zimmer MedizinSysteme GmbH
- Endo International PLC
- Merz Pharma GmbH & Co. KGaA
Methodology
LOADING...
